Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Accured Expenses: 2013-2024

Historic Change in Accured Expenses for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to $4.3 million.

  • Wave Life Sciences' Change in Accured Expenses fell 0.12% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 54.48%. This contributed to the annual value of $4.3 million for FY2024, which is 687.43% up from last year.
  • As of FY2024, Wave Life Sciences' Change in Accured Expenses stood at $4.3 million, which was up 687.43% from -$724,000 recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Change in Accured Expenses ranged from a high of $4.3 million in FY2024 and a low of -$4.2 million during FY2020.
  • In the last 3 years, Wave Life Sciences' Change in Accured Expenses had a median value of $2.7 million in 2022 and averaged $2.1 million.
  • As far as peak fluctuations go, Wave Life Sciences' Change in Accured Expenses crashed by 391.02% in 2020, and later skyrocketed by 687.43% in 2024.
  • Wave Life Sciences' Change in Accured Expenses (Yearly) stood at -$4.2 million in 2020, then surged by 168.58% to $2.9 million in 2021, then fell by 6.89% to $2.7 million in 2022, then plummeted by 126.90% to -$724,000 in 2023, then soared by 687.43% to $4.3 million in 2024.